Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | MMP9 | P14780 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | MMP2 | P08253 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | MMP8 | P22894 | 1/20 | 0.44 |
| ▸ | CCR1 | P32246 | 1/20 | 0.44 |
| ▸ | THPO | P40225 | 1/20 | 0.44 |
| ▸ | MTOR | P42345 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MMP13 | P45452 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21131741 | 0.99 | MMP9 (0.43) | KDM4ETP53MMP9SMN1; SMN2MMP2 | |
| SCHEMBL21131854 | 0.97 | BRD4 (0.45) | KDM4ETP53MMP9SMN1; SMN2MMP2 | |
| SCHEMBL17829343 | 0.96 | KDM4E (0.46) | KDM4ETP53MMP9SMN1; SMN2MMP2 | |
| SCHEMBL20226100 | 0.94 | KDM4E (0.44) | KDM4ETP53MMP9SMN1; SMN2MMP2 | |
| SCHEMBL17829322 | 0.93 | TOP1 (0.49) | KDM4ETP53MMP9SMN1; SMN2MMP2 | |
| SCHEMBL17829327 | 0.93 | TOP1 (0.49) | KDM4ETP53MMP9SMN1; SMN2MMP2 | |
| SCHEMBL22071902 | 0.93 | TDP1 (0.46) | KDM4ETP53MMP9SMN1; SMN2MMP2 | |
| SCHEMBL17755351 | 0.93 | KDM4E (0.46) | KDM4ETP53MMP9SMN1; SMN2MMP2 | |
| SCHEMBL17829454 | 0.93 | BRD4 (0.48) | KDM4ETP53MMP9SMN1; SMN2MMP2 | |
| SCHEMBL12580382 | 0.91 | MMP2 (0.48) | KDM4ETP53MMP9SMN1; SMN2MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11211563-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2021-12-28 | — | — | US | disclosed |
| US-20190198766-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2019-06-27 | — | — | US | disclosed |
| US-9502669-B2 | Organic light emitting diode | LG CHEM, LTD. (KR) | 2016-11-22 | — | — | US | disclosed |
| US-9502669-B2 | Organic light emitting diode | LG CHEM, LTD. (KR) | 2016-11-22 | — | — | US | disclosed |
| US-20160293852-A1 | ORGANIC LIGHT EMITTING DIODE | LG CHEM, LTD. (KR) | 2016-10-06 | — | — | US | disclosed |
| US-20160293852-A1 | ORGANIC LIGHT EMITTING DIODE | LG CHEM, LTD. (KR) | 2016-10-06 | — | — | US | disclosed |
| US-20160172598-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
| US-20160172598-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2016-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160172598-A1 | HETERO RING COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | CRY1, CRY2, PER2 | KDM4E 1590/4885TP53 2330/4885MMP9 3689/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.